ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is 180 Life Sciences Corp. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -1.00% and Operating profit at -329.35% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.60
2
The company has declared negative results in Mar'2025 after 5 consecutive positive quarters
- PRE-TAX PROFIT(Q) At USD -1.73 MM has Fallen at -1,087.52%
- NET PROFIT(Q) At USD -1.73 MM has Fallen at -1,087.52%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -54.32%, its profits have risen by 71%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -54.32% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is 180 Life Sciences Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
180 Life Sciences Corp.
-48.74%
0.61
919.10%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.00%
EBIT Growth (5y)
-329.35%
EBIT to Interest (avg)
-6.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.01
Tax Ratio
4.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.38%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.77
EV to EBIT
-0.37
EV to EBITDA
-0.38
EV to Capital Employed
0.57
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-153.04%
ROE (Latest)
-42.26%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -3.15 MM
NET PROFIT(HY)
Higher at USD -4.1 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-13What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -1.73 MM has Fallen at -1,087.52%
NET PROFIT(Q)
At USD -1.73 MM has Fallen at -1,087.52%
Here's what is working for 180 Life Sciences Corp.
Operating Cash Flow
Highest at USD -3.15 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for 180 Life Sciences Corp.
Pre-Tax Profit
At USD -1.73 MM has Fallen at -1,087.52%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -1.73 MM has Fallen at -1,087.52%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
